Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04403074 · ClinicalTrials.gov registry record
Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis (EUS-CPN) for Chronic Pancreatitis
A clinical trial of Chronic Pancreatitis, sponsored by Indiana University.
- Recruiting
- Registry status
- 35
- Enrollment target
- 1
- Study location
NCT04403074: Recruiting study of Chronic Pancreatitis, sponsored by Indiana University.
NCT04403074 is a study of Chronic Pancreatitis that is actively recruiting participants, run by Indiana University. The registered enrollment target is 35 participants, below the 688-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04403074, a study of Chronic Pancreatitis, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
Physicians need a tracking system for specific treatment modalities, and data to determine the impact of endoscopic ultrasound pain management for patients with chronic pancreatitis.
Primary Outcome
Use of pain medication (by using morphine equivalents) for each patient will be tracked weekly for up to 24 weeks post CPN to track pain management/relief for the of patients. There should be a lessening in use of pain medication as time progesses.
Conditions Studied
Interventions
- PROCEDURE Celiac Plexus Neurolysis
Study Locations (1)
Indiana
- Indiana University Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2017-10-20 |
| Est. Completion | 2029-10-20 |
What NCT04403074 shows while recruiting
NCT04403074 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 688-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Chronic Pancreatitis appearing as the primary indexed condition, and to 1 intervention - of which Celiac Plexus Neurolysis is the first listed.
NCT04403074 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT04403074 about?
NCT04403074 is a clinical study titled "Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis (EUS-CPN) for Chronic Pancreatitis". Physicians need a tracking system for specific treatment modalities, and data to determine the impact of endoscopic ultrasound pain management for patients with chronic pancreatitis.
What is the current status of trial NCT04403074?
This trial is currently recruiting. The enrollment target is 35 participants. The study started on 2017-10-20. Estimated completion is 2029-10-20.
What conditions does trial NCT04403074 study?
This clinical trial studies the following conditions: Chronic Pancreatitis.
What interventions are being tested in trial NCT04403074?
The interventions under investigation include: Celiac Plexus Neurolysis (PROCEDURE).
Who is sponsoring clinical trial NCT04403074?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04403074 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pancreatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04403074's enrollment target sits among peer trials
35 29th of 42 higher than 13 of 42 other Chronic Pancreatitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pancreatitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
RECRUITING
-
Analysis of Graft Function Following Autologous Islet Transplantation
RECRUITING
-
A PiLot ClinicaL TrIal of ParicAlcitol for ChroNiC PancrEatitis
RECRUITING · Early Phase 1
-
Scrambler Therapy in Chronic Pancreatitis
RECRUITING · NA
-
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
RECRUITING
-
Pancreas Registry and High Risk Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI